SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Cardiology Referral — Benny Leonard

PatientBenny Leonard
Date of birth1976-04-07
IdentifiersMRN HR-BX008-SYN; SSN (made up) 000-08-4106
Document date2026-05-12
AuthorMiriam Okafor-Rosenthal, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

A 50-year-old professional boxing referee and boxing instructor with newly found stage 2 hypertension, left ventricular hypertrophy by voltage on the ECG, and two months of breathlessness and chest tightness late in long nights of refereeing in hot arenas. Please evaluate the symptoms and the hypertrophy, advise on his coronary and sudden cardiac death risk, and say whether and how he can keep refereeing. [S]

Urgency: Soon, within two weeks; he is refereeing only short undercards until seen. [S]

Questions for the consultant:

History of Present Illness

Former world lightweight champion; referees whole cards of six to eight bouts several nights a week and teaches boxing. For about two months, late in long cards in hot arenas, breathlessness and tightness across the chest when moving quickly, easing within a few minutes of rest; never at rest; no fainting, palpitations, orthopnea or ankle swelling. Found at his yearly license examination to have blood pressure 164/100 and 160/98 mmHg, untreated. ECG today: sinus rhythm, left ventricular hypertrophy by voltage (Sokolow-Lyon 38 mm, Cornell 24 mm) with mild lateral T-wave flattening, QTc 418 ms, no Q waves or pre-excitation. Laboratory tests today: creatinine 0.98 mg/dL, potassium 4.1 mmol/L, HbA1c 5.5%, TSH 1.9, urine albumin-to-creatinine ratio 22 mg/g, total cholesterol 234, LDL 160, HDL 44 mg/dL, lipoprotein(a) 42 nmol/L. Never smoked; little alcohol. Family history not known. Started today on losartan 50 mg with hydrochlorothiazide 12.5 mg with home monitoring. Money is tight since he lost his savings years ago, and he is anxious about his license; please favor low-cost generic medicines [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

2 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Losartan 50 mg with hydrochlorothiazide 12.5 mg, one tablet each morningOne tablet each morningOral route2026-05-12 to 2026-06-30completedS

Problems

ProblemClinical statusVerificationCodeProvenance
Breathlessness and tightness across the chest on exertion for about two months, late in long nights of refereeing in hot arenas, easing within a few minutes of rest; never at rest; no fainting, palpitations, orthopnea or ankle swelling; cause under evaluation with a cardiology consultationactiveconfirmed R06.09S — Synthetic presenting problem anchored to his documented work as a referee; superseded at the consultation when stress testing showed no ischemia and the symptom was attributed to hypertensive heart disease.
Stage 2 hypertension found at a yearly fitness examination for his referee's license (164/100 and 160/98 mmHg), with left ventricular hypertrophy by voltage on the ECG; untreated; home readings to followactiveconfirmed I10S — Synthetic diagnosis at intake; reclassified as hypertensive heart disease after the echocardiogram at the consultation.
Hypercholesterolemia: LDL 160 mg/dL, HDL 44 mg/dL, lipoprotein(a) not raised; no diabetesactiveconfirmed E78.00S — Synthetic diagnosis at intake.

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

No historical medical events are recorded.

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-05-12Body height165cmS
2026-05-12Body weight74.6kgS
2026-05-12Body mass index (BMI) [Ratio]27.4kg/m2S
2026-05-12Systolic blood pressure164mm[Hg]S
2026-05-12Diastolic blood pressure100mm[Hg]S
2026-05-12Heart rate78/minS
2026-05-12Respiratory rate16/minS
2026-05-12Body temperature36.7CelS
2026-05-12Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-05-12Sodium [Moles/volume] in Serum or Plasma140mmol/L135-146 mmol/LNormalS
2026-05-12Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.3 mmol/LNormalS
2026-05-12Urea nitrogen [Mass/volume] in Serum or Plasma15mg/dL7-25 mg/dLNormalS
2026-05-12Creatinine [Mass/volume] in Serum or Plasma0.98mg/dL0.7-1.3 mg/dLNormalS
2026-05-12Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M93mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-05-12Glucose [Mass/volume] in Serum or Plasma96mg/dL65-99 mg/dLNormalS
2026-05-12Hemoglobin [Mass/volume] in Blood14.6g/dL13.5-17.5 g/dLNormalS
2026-05-12Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L7-55 U/LNormalS
2026-05-12Hemoglobin A1c/Hemoglobin.total in Blood5.5%<=5.6%NormalS
2026-05-12Thyrotropin [Units/volume] in Serum or Plasma1.9m[IU]/L0.4-4.5 mIU/LNormalS
2026-05-12Albumin/Creatinine [Mass Ratio] in Urine22mg/g{creat}<=29 mg/g{creat}NormalS
2026-05-12Cholesterol [Mass/volume] in Serum or Plasma234mg/dL<=199 mg/dLHighS
2026-05-12Cholesterol in HDL [Mass/volume] in Serum or Plasma44mg/dL>=40 mg/dLNormalS
2026-05-12Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation160mg/dL<=99 mg/dLHighS
2026-05-12Triglyceride [Mass/volume] in Serum or Plasma150mg/dL<=149 mg/dLHighS
2026-05-12Lipoprotein a [Moles/volume] in Serum or Plasma42nmol/L<=124 nmol/LNormalS
2026-05-12Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S
2026-05-12Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]6{score}S
2026-05-12Total score [AUDIT-C]2{score}S

Assessment

Plan of Treatment